Sonnet BioTherapeutics Holdings Total Assets 2006-2021 | SONN

Sonnet BioTherapeutics Holdings total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Sonnet BioTherapeutics Holdings Annual Total Assets
(Millions of US $)
2021 $29
2020 $8
2019 $32
2019 $0
2018 $30
2017 $30
2016 $33
2015 $42
2014 $36
2013 $20
2012 $8
2012 $1
2011 $5
2011 $0
2010 $2
2009 $2
2008 $3
2007 $5
2006 $3
2005 $3
Sonnet BioTherapeutics Holdings Quarterly Total Assets
(Millions of US $)
2021-09-30 $29
2021-06-30 $7
2021-03-31 $8
2020-12-31 $3
2020-09-30 $8
2020-06-30 $4
2020-03-31 $31
2019-12-31 $0
2019-09-30 $0
2019-06-30 $45
2019-03-31 $48
2018-12-31 $0
2018-09-30 $30
2018-06-30 $31
2018-03-31 $29
2017-12-31 $0
2017-09-30 $32
2017-06-30 $33
2017-03-31 $33
2016-12-31 $0
2016-09-30 $34
2016-06-30 $37
2016-03-31 $41
2015-12-31 $0
2015-09-30 $43
2015-06-30 $43
2015-03-31 $43
2014-12-31 $0
2014-09-30 $40
2014-06-30 $29
2014-03-31 $26
2013-12-31 $0
2013-09-30 $16
2013-06-30 $9
2013-03-31 $7
2012-12-31 $0
2012-09-30 $8
2012-06-30 $10
2012-03-31 $6
2011-12-31 $0
2011-09-30 $2
2011-06-30 $2
2011-03-31 $2
2010-12-31 $1
2010-09-30 $2
2010-06-30 $2
2010-03-31 $1
2009-12-31 $1
2009-09-30 $2
2009-06-30 $3
2009-03-31 $2
2008-12-31 $2
2008-09-30 $3
2008-06-30 $4
2008-03-31 $4
2007-12-31 $4
2007-09-30 $5
2007-06-30 $3
2007-03-31 $2
2006-12-31 $3
2006-09-30 $3
2006-06-30 $3
2006-03-31 $3
2005-12-31 $3
2005-09-30 $0
2005-06-30 $0
2005-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.019B $0.000B
Sonnet BioTherapeutics Holdings Inc. is an oncology-focused biotechnology company with a proprietary platform for biologic drugs of single or bispecific action. Sonnet BioTherapeutics Holdings Inc., formerly known as Chanticleer Holdings Inc., is based in PRINCETON, N.J.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.036B 8.91
Bio-Rad Laboratories (BIO.B) United States $17.472B 35.46
QIAGEN (QGEN) Netherlands $11.101B 18.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.210B 0.00
Emergent Biosolutions (EBS) United States $2.527B 9.09
Arcus Biosciences (RCUS) United States $2.184B 0.00
Myovant Sciences (MYOV) United Kingdom $1.260B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.080B 0.00
Zymeworks (ZYME) Canada $0.522B 0.00
SQZ Biotechnologies (SQZ) United States $0.201B 0.00
Ambrx Biopharma (AMAM) United States $0.191B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.81